Inconsistencies of absolute drug-drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs (2023) Weisbach L, Schuster AK, Hartmann M, Dürr P, Then M, Andrikyan W, Fromm M, et al. Journal article, Original article Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia. (2023) Terzić V, Levoyer L, Figarella M, Mercier N, De Gastines L, Gibowski S, Demotes J, et al. Journal article, Review article Pharmacokinetics, pharmacodynamics and safety of BAY 2433334, a novel activated factor XI inhibitor, in healthy volunteers: A randomized phase 1 multiple-dose study. (2022) Kubitza D, Heckmann M, Distler J, Koechel A, Schwers S, Kanefendt F Journal article Use of medication data alone to identify diagnoses and related contraindications: Application of algorithms to close a common documentation gap (2022) Andrikyan W, Then M, Gassmann KG, Tuemena T, Dürr P, Fromm M, Maas R Journal article c4c: Paediatric pharmacovigilance: Methodological considerations in research and development of medicines for children - A c4c expert group white paper (2021) Aurich B, Apele-Freimane D, Banaschewski T, Chouchana L, Day S, Kaguelidou F, Kelly LE, et al. Journal article, Review article The CredibleMeds® list: Usage of QT interval prolonging drugs in Germany and discordances with prescribing information (2021) Then M, Andrikyan W, Maas R, Fromm M Journal article Safety of clonidine used for long-term sedation in paediatric intensive care: A systematic review (2020) Eberl S, Ahne G, Toni I, Standing J, Neubert A Journal article, Review article Effects of single green tea ingestion on pharmacokinetics of nadolol in healthy volunteers (2020) Misaka S, Abe O, Ono T, Ono Y, Ogata H, Miura I, Shikama Y, et al. Journal article Safety and immunogenicity of Fc-EDA, a recombinant ectodysplasin A1 replacement protein, in human subjects (2020) Körber I, Klein OD, Morhart P, Faschingbauer F, Grange DK, Clarke A, Bodemer C, et al. Journal article Effects of the nitric oxide synthase inhibitor ronopterin (VAS203) on renal function in healthy volunteers (2019) Ott C, Bosch A, Winzer N, Friedrich S, Schinzel R, Tegtmeier F, Schmieder R Journal article